Endothelin-1 (ET-1) is a peptide with vasoconstrictive properties that plays a crucial role in regulating blood vessel tone, blood pressure, and cardiovascular function. ET-1 Activators refer to substances or mechanisms that can influence or enhance the activity of this specific peptide. The endothelin system consists of three isoforms (ET-1, ET-2, and ET-3) and two receptor subtypes (ETAR and ETBR) found in various tissues, including the endothelium, heart, lungs, and kidneys. ET-1 itself is primarily produced by vascular endothelial cells and functions as a potent vasoconstrictor when it binds to its receptors on smooth muscle cells in blood vessels.
The activation of the ET-1 system can have profound effects on the cardiovascular system, including increasing blood pressure and contributing to vascular remodeling in diseases like hypertension. Understanding ET-1 Activators is important for comprehending the intricate regulatory mechanisms that control vascular tone and blood pressure. Researchers investigate how various factors, including hormones, cytokines, and mechanical stress, can activate the production and release of ET-1. This knowledge is fundamental in unraveling the complex pathophysiology of conditions related to blood vessel dysfunction and may ultimately lead to novel approaches for managing cardiovascular diseases. In summary, ET-1 Activators encompass substances or processes that can modulate the activity of endothelin-1, a key player in vascular physiology and cardiovascular health.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Stimulates ET-1 synthesis and release in vascular endothelial and smooth muscle cells via the AT1 receptor. | ||||||
Thrombin from human plasma | 9002-04-4 | sc-471713 | 100 U | $235.00 | ||
Induces ET-1 expression in endothelial cells, potentially through protease-activated receptor (PAR) signaling. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Increases ET-1 production in vascular endothelial cells, potentially linked to insulin resistance and vascular dysfunction. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Can modulate ET-1 expression in certain tissues, with potential vasoprotective effects. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
SERCA pump inhibitor depleting Ca2+ stores and activating CaM kinases phosphorylating CREB bound to ET-1 cAMP response elements. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid receptor ligand interacts with GRE sites at the ET-1 promoter region. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
HDAC inhibitor modulating histone acetylation status of the ET-1 locus for augmented expression. | ||||||